Showing results (191-200 of 499) with videos related to

Sort By:
Pageof 50
Molecules (Basel, Switzerland)|April 3, 2021
Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 InfectionXinling Wang, Miao Cao, Yanling Wu, et al.
European Journal of Pharmacology|January 30, 2019
Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude miceChenglai Xia, Zhihong He, Shaofen Liang, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formationAndrew Vaillant, Jean-Marc Juteau, Hong Lu, et al.
Microbes and Infection|September 12, 2017
Genomic signature analysis of the recently emerged highly pathogenic A(H5N8) avian influenza virus: implying an evolutionary trend for bird-to-human transmissionWei Xu, Yanyan Dai, Chen Hua, et al.
AIDS (London, England)|January 26, 2017
A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activityShan Su, Qian Wang, Wei Xu, et al.
Molecules (Basel, Switzerland)|March 24, 2019
A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-LifeShan Su, Giselle Rasquinha, Lanying Du, et al.
Virus Genes|June 28, 2012
Phylogenetic and biological analysis of a laboratory-generated gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV)Xiaochu Ma, Shiying Zhou, Meili Wei, et al.
Biochemical and Biophysical Research Communications|April 3, 2007
HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to HBMECAmbrose Y Jong, Chu-Hua Wu, Shibo Jiang, et al.
The Biochemical Journal|June 15, 2011
HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to human brain microvascular endothelial cells via gp41 core-induced membrane activitiesSheng-He Huang, Chu-Hua Wu, Shibo Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitorsMing-xin Dong, Lu Lu, Haitao Li, et al.
Pageof 50